Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian
Condition: Metastatic Ovarian Cancer Interventions: Drug: Fludarabine; Radiation: Radiation; Biological: TIL administration; Drug: IL-2 Sponsor: Sheba Medical Center Not yet recruiting
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου